GC MOGAM Trademark

Trademark Overview


On Thursday, July 28, 2016, a trademark application was filed for GC MOGAM with the United States Patent and Trademark Office. The USPTO has given the GC MOGAM trademark a serial number of 87119997. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 12, 2020. This trademark is owned by Green Cross Holdings Corporation. The GC MOGAM trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, Japanese Encephalitis, hepatitis, HIV, Hunter syndrome, hemophilia, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, clostridium tetani, influenza, chronic pain and kidney diseases; pharmaceutical preparations for use in ocular or intraocular surgery, chemotherapy, dermatology and urology; blood plasma derivatives for medical purposes; vaccines; enzyme preparations for medical purposes; protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing and treatm...

Wholesale distributorships and retail stores featuring pharmaceutical products; Export and import agencies in the field of pharmaceutical products; Financial intermediary services, namely, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of pharmaceutical products and medical equipment; Operation of a business for others, namely, wholesale distributorships and retail stores featuring pharmaceutical products; Procurement, namely, purchasing pharmaceutical products for other businesses

Research and development, laboratory and scientific research in the field of pharmaceuticals, vaccines, blood plasma preparations, recombinant proteins and antibodies
gc mogam

General Information


Serial Number87119997
Word MarkGC MOGAM
Filing DateThursday, July 28, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 12, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2017

Trademark Statements


Goods and ServicesPharmaceuticals for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, Japanese Encephalitis, hepatitis, HIV, Hunter syndrome, hemophilia, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, clostridium tetani, influenza, chronic pain and kidney diseases; pharmaceutical preparations for use in ocular or intraocular surgery, chemotherapy, dermatology and urology; blood plasma derivatives for medical purposes; vaccines; enzyme preparations for medical purposes; protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing and treatment of hepatitis B and influenza
Goods and ServicesWholesale distributorships and retail stores featuring pharmaceutical products; Export and import agencies in the field of pharmaceutical products; Financial intermediary services, namely, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of pharmaceutical products and medical equipment; Operation of a business for others, namely, wholesale distributorships and retail stores featuring pharmaceutical products; Procurement, namely, purchasing pharmaceutical products for other businesses
Goods and ServicesResearch and development, laboratory and scientific research in the field of pharmaceuticals, vaccines, blood plasma preparations, recombinant proteins and antibodies
Pseudo MarkGREEN CROSS MOGAM

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 2, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, August 2, 2016
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateNOT AVAILABLE
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGreen Cross Holdings Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressYongin-si, Gyeonggi-do 16924
KR

Party NameGreen Cross Holdings Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressYongin-si, Gyeonggi-do
KR

Trademark Events


Event DateEvent Description
Tuesday, October 13, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 12, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 11, 2020EXTENSION 5 GRANTED
Tuesday, March 3, 2020EXTENSION 5 FILED
Wednesday, March 11, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 3, 2020TEAS EXTENSION RECEIVED
Wednesday, August 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 12, 2019EXTENSION 4 GRANTED
Monday, August 12, 2019EXTENSION 4 FILED
Monday, August 12, 2019TEAS EXTENSION RECEIVED
Thursday, February 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 12, 2019EXTENSION 3 GRANTED
Tuesday, February 12, 2019EXTENSION 3 FILED
Tuesday, February 12, 2019TEAS EXTENSION RECEIVED
Thursday, September 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 4, 2018EXTENSION 2 GRANTED
Tuesday, September 4, 2018EXTENSION 2 FILED
Tuesday, September 4, 2018TEAS EXTENSION RECEIVED
Thursday, February 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 30, 2018EXTENSION 1 GRANTED
Tuesday, January 30, 2018EXTENSION 1 FILED
Tuesday, January 30, 2018TEAS EXTENSION RECEIVED
Tuesday, September 5, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 11, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 21, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 2, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 2, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 2, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 26, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, April 29, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, April 29, 2017FINAL REFUSAL E-MAILED
Saturday, April 29, 2017FINAL REFUSAL WRITTEN
Friday, April 28, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, April 16, 2017ASSIGNED TO LIE
Tuesday, April 4, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 8, 2016NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, November 8, 2016PRIORITY ACTION E-MAILED
Tuesday, November 8, 2016PRIORITY ACTION WRITTEN
Tuesday, November 8, 2016ASSIGNED TO EXAMINER
Wednesday, August 3, 2016NOTICE OF PSEUDO MARK E-MAILED
Tuesday, August 2, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 1, 2016NEW APPLICATION ENTERED IN TRAM